Vanguard Global Advisers »

BioCryst Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $935k 98k 9.52

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
RA Capital Management
Deerfield Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
TCG Crossover Management
Henderson Group
Perceptive Advisors
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Kynam Capital Management
Bank of America Corporation

View all funds holding BioCryst Pharmaceuticals